Back to Search
Start Over
Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study
- Source :
- Nutrition, Metabolism and Cardiovascular Diseases. 21:699-705
- Publication Year :
- 2011
- Publisher :
- Elsevier BV, 2011.
-
Abstract
- Background and Aim: We evaluated the relationship between insulin resistance (IR) and insulin secretion with the metabolic syndrome (MS) in 885 subjects (377 men/508 women, age 49 11 years, BMI 29 5.2 kgm2) at risk of diabetes enrolled in the genetics, pathophysiology and evolution of type 2 diabetes (GENFIEV) study. Methods and Results: All subjects underwent a 75-g oral glucose tolerance test (OGTT) for the estimation of plasma levels of glucose and C-peptide, as well as fasting insulin and lipid profile. IR was arbitrarily defined as HOMA-IR value above the 75th centile of normal glucose tolerance (NGT) subjects. Overall MS prevalence (National Cholesterol Treatment Panel-Adult Treatment Panel (NCEP-ATPIII) criteria) was 33%, 19% in subjects with NGT, 42% in impaired fasting glucose (IFG), 34% in impaired glucose tolerance (IGT), 74% in IFG + IGT subjects, and 56% in newly diagnosed diabetic patients. Prevalence was slightly higher with IDF criteria. MS prevalence was >50% in subjects with 2 h glucose >7.8 mmol l-1, independently of fasting plasma glucose. IR prevalence was higher in subjects with MS than in those without (63% vs. 23%; p < 0.0001) and increased from 54% to 73% and 88% in the presence of three, four or five traits, respectively. IR occurred in 42% of subjects with non-diabetic alterations of glucose homeostasis, being the highest in those with IFG + IGT (IFG + IGT 53%, IFG 45%, IGT 38%; p < 0.0001). Individuals with MS were more IR irrespective of glucose tolerance (p < 0.0001) with no difference in insulinogenic index. Hypertriglyceridaemia (OR: 3.38; Confidence Interval, CI: 2.294.99), abdominal obesity (3.26; CI: 2.18-4.89), hyperglycaemia (3.02; CI: 1.80-5.07) and hypertension (1.69; CI: 1.12-2.55) were all associated with IR. Conclusions: These results show that in subjects with altered glucose tolerance (in particular IFG + IGT) MS prevalence is high and is generally associated to IR. Some combinations of traits of MS may significantly contribute to identify subjects with IR.
- Subjects :
- Blood Glucose
Male
insulin secretion
endocrine system diseases
Endocrinology, Diabetes and Metabolism
Medicine (miscellaneous)
prediabetes
Type 2 diabetes
Impaired glucose tolerance
Risk Factors
insulin resistance
Prevalence
Prediabetes
Glucose tolerance test
Nutrition and Dietetics
C-Peptide
medicine.diagnostic_test
type 2 diabetes
metabolic syndrome
impaired glucose regulation
GENFIEV study
Metabolic Syndrome X
Middle Aged
Italy
Hypertension
Female
Cardiology and Cardiovascular Medicine
Type 2
Adult
medicine.medical_specialty
Prediabetic State
Insulin resistance
Diabetes mellitus
Internal medicine
Glucose Intolerance
Diabetes Mellitus
medicine
Humans
business.industry
nutritional and metabolic diseases
Settore MED/13 - ENDOCRINOLOGIA
Glucose Tolerance Test
medicine.disease
Impaired fasting glucose
Logistic Models
Endocrinology
Diabetes Mellitus, Type 2
Hyperglycemia
Metabolic syndrome
business
Subjects
Details
- ISSN :
- 09394753
- Volume :
- 21
- Database :
- OpenAIRE
- Journal :
- Nutrition, Metabolism and Cardiovascular Diseases
- Accession number :
- edsair.doi.dedup.....dec61a3c904bd99dec494a2d9a9899ae